Radiotherapy Market Synopsis:
Radiotherapy Market Size Was Valued at USD 11.19 Billion in 2023, and is Projected to Reach USD 16.29 Billion by 2032, Growing at a CAGR of 4.26% From 2024-2032.
Radiotherapy market means the application of ionizing radiation within an external beam method to cancer diseases and some others. It uses different kinds of radiation to destroy the cancer cells either from outside or from inside the body. Primary and adjuvant to surgery and chemotherapy are the major applications of radiotherapy.
Radiation therapy is one of the most commonly used modalities for the management of cancer, the main type of treatment in oncology. It is prescribed in a single formula or along with other treatments as surgery, chemotherapy, or immunotherapy. Radiotherapy market has expanded significantly over the last few years because of the rising cancer rate across the world. Innovations strife in radiotherapy includes precision radiotherapy, and stereotactic body radiotherapy known to have enhanced results with minimal health complication. Linac and proton therapy systems have developed high precision radiotherapy capable of delivering tumour specific conformal radiation doses make radiotherapy an integral part of contemporary oncology.
The market is projected to grow at a steady pace due to the following factors the global population is aging, the worldwide incidents of cancer are rising, and there is advancement in the health care amenities. The need for radiography treatments is specifically high within the developed countries due comprehensive access to the technological enhancements and availability of progressive treatments. In developed markets, rising concern for healthier living and rising burden of cancer is opening new doors for growth in health care access. Additionally, the market has more new technologies in store such as an application of Artificial Intelligence (AI) in treatment planning as well as increasing efficacy of radiotherapy procedures. But high costs of treatment, scarcity of skilled personnel, and official barriers still pose a threat to the growth of the market.
.webp)
Radiotherapy Market Trend Analysis:
Adoption of Precision Radiotherapy
- The two major trends that have been keenly observed to exist in the radiotherapy market today is Precision radiotherapy. This method employs the sophisticated imaging and diagnostic instruments with a view to providing treatment regimens that correspond to the specific tumor features of the patient. Coming to the type of radiation, there are new methods such as intensity modulated radiation therapy or IMRT, proton therapy, stereotactic radiotherapy to name a few that have made it possible to do a much better job of focusing the tumour destroying radiation while sparing a good deal of the surrounding healthy tissue. This trend has developed due to the enhanced accuracy of imaging in tumor localization and treatment planning facilitated by MRI and PET scans.
- The increased use of precision radiotherapy enhances patient outcomes, as well as cuts down the adverse effects experienced. Combination therapy approaches are bringing high value in radiotherapy facility and intro complex situations like involving sensitive body organs. Furthermore, they believe that this shall expand healthcare providers’ option to make use of these advanced methods in radiotherapy hence contributing to general market expansion. It is expected that an increased use of AI and particularly machine learning in treatment planning and monitoring will feed into a further development of precision based radiotherapy and results in enhanced opportunities for individual patient treatment.
Expansion in Emerging Markets
- A major opportunity exists in the radiotherapy market due to expansion in the emerging markets. In Asi-Pacific, Latin American and Middle Eastern countries people are experiencing economic growth and improvements in health care system which has created demand for effective cancer treatments. Radiotherapy is not widely available across these regions; there is an improvement in cancer incidence rates because of such aspects such as urbanization and changes in lifestyles, thus, justification of radiotherapy. The global market for cancer molecular diagnostics is expected to expand in those regions due to strengthening of healthcare related investments including opening of molecular diagnostic centers for cancer treatment.
- The potentiality to expand also comes from the fact that radiotherapy technologies and equipment remains cheap and readily available in emerging economies. The radiotherapy industry has realized the potential of the growing need for cancer treatment in these regions therefore the current efforts on developing cost efficient solutions for these markets. Governments across these regions are also chasing after the cause of raising the access to health care which in turn contributes to the increased use of radiotherapy. Consequently, there are projected to be heightened sales of radiotherapy in emerging markets in the coming years.
Radiotherapy Market Segment Analysis:
Radiotherapy Market is Segmented on the basis of Type, Technology, Application, End User, and Region.
By Type, External Beam Radiotherapy segment is expected to dominate the market during the forecast period
- The radiotherapy market pertains to products that are used in delivering radiation treatment, including radiation therapy devices and systems including the linear accelerator, proton therapy machines and Brachytherapy devices. The key factors that have led to the promotion of this market are enhanced technologies that facilitate improved enhanced cancer treatment. These products are getting complex, enabling high-resolution imaging and artificial intelligence-based treatment planning systems to enhance the quality of radiotherapy.
- The heightened usage of equipment including proton therapy systems and stereotactic radiotherapy equipment has helped fuel demand of radiotherapy. These integrated devices enhance the accuracy in tumor localization, reducing the impact of the treatment on normal tissues, and enhancing patient’s quality of life during treatment. Since hospitals and other healthcare services are also progressing towards the acquisition of advanced radiotherapy equipment, based on increasing popularity of customized as well as targeted therapies all across the world, the product segment is anticipated to increase.
By Application, Prostate Cancer segment expected to held the largest share
- The market for radiotherapy is also split depending on the type of cancer: prostate, breast, lung, colorectal and head and neck and others. Prostate cancer is one with the most frequent indications for radiotherapy and brachytherapy and external beam radiotherapy are the most common types of therapies in this type of cancer treatment. Likewise, breast cancer is also a large segment of the market for perfumery; after surgery, radiotherapy may be used to take out any remaining cancerous cells.
- Lung cancer, Colorectal cancer and head and neck cancers are other areas where radiotherapy is used extensively. Patients diagnosed with lung cancer are usually treated with radiotherapy with chemotherapy, particularly in NSCLC patients. Radiotherapy as a treatment may be useful in the treatment of colorectal cancer whether for tumour downsizing before surgery or as an adjuvant treatment to remove all cancer cells after surgery especially for Rectal cancer. Cancers of the head and neck such as mouth, throat, and larynx cancers are like many other cancers that are treated using radiotherapy.
Radiotherapy Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- North America is the leadership region as for the radiotherapy market, influenced by the presence of a developed healthcare system, a high level of spending on healthcare, and the growing incidence of cancer. The United States has the largest market for radiotherapy because American consumers are served by market leading healthcare suppliers, research organizations, medical technologies, and leading healthcare equipment manufacturers. The adaptation of new radiotherapy technologies which include the proton therapy and stereotactic radiosurgery is more common to North American region than that in other regions because the health care systems in the region are more inclined to support modern treatments.
- Moreover, the increasing demand of cancer products for elderly people and for cancer research in the region is also indicated by the demand for radiotherapy. The constant development and tremendous growth of the specialized cancer centers as well as the emerging precision medicine also boost the market of this region.
Active Key Players in the Radiotherapy Market:
- Varian Medical Systems (USA)
- Siemens Healthineers (Germany)
- Elekta AB (Sweden)
- Accuray Incorporated (USA)
- Canon Medical Systems Corporation (Japan)
- GE Healthcare (USA)
- IBA (Belgium)
- RaySearch Laboratories AB (Sweden)
- Sumitomo Heavy Industries (Japan)
- Isoray, Inc. (USA)
- ViewRay, Inc. (USA)
- Mitsubishi Electric Corporation (Japan)
- Other Active Players
|
Radiotherapy Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 11.19 Billion |
|
Forecast Period 2024-32 CAGR: |
4.26% |
Market Size in 2032: |
USD 16.29 Billion |
|
Segments Covered: |
By Type |
|
|
|
By Technology |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Radiotherapy Market by Type
4.1 Radiotherapy Market Snapshot and Growth Engine
4.2 Radiotherapy Market Overview
4.3 External Beam Radiotherapy
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 External Beam Radiotherapy: Geographic Segmentation Analysis
4.4 Internal Beam Radiotherapy (Brachytherapy)
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Internal Beam Radiotherapy (Brachytherapy): Geographic Segmentation Analysis
4.5 Systemic Radiotherapy
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Systemic Radiotherapy: Geographic Segmentation Analysis
Chapter 5: Radiotherapy Market by Technology
5.1 Radiotherapy Market Snapshot and Growth Engine
5.2 Radiotherapy Market Overview
5.3 Intensity-Modulated Radiation Therapy (IMRT)
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Intensity-Modulated Radiation Therapy (IMRT): Geographic Segmentation Analysis
5.4 Image-Guided Radiation Therapy (IGRT)
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Image-Guided Radiation Therapy (IGRT): Geographic Segmentation Analysis
5.5 Stereotactic Technology
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Stereotactic Technology: Geographic Segmentation Analysis
5.6 Proton Beam Therapy
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Proton Beam Therapy: Geographic Segmentation Analysis
5.7 3D Conformal Radiotherapy
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 3D Conformal Radiotherapy: Geographic Segmentation Analysis
5.8 Others
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Others: Geographic Segmentation Analysis
Chapter 6: Radiotherapy Market by Application
6.1 Radiotherapy Market Snapshot and Growth Engine
6.2 Radiotherapy Market Overview
6.3 Prostate Cancer
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Prostate Cancer: Geographic Segmentation Analysis
6.4 Breast Cancer
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Breast Cancer: Geographic Segmentation Analysis
6.5 Lung Cancer
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Lung Cancer: Geographic Segmentation Analysis
6.6 Colorectal Cancer
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Colorectal Cancer: Geographic Segmentation Analysis
6.7 Head and Neck Cancer
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Head and Neck Cancer: Geographic Segmentation Analysis
6.8 Others
6.8.1 Introduction and Market Overview
6.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.8.3 Key Market Trends, Growth Factors and Opportunities
6.8.4 Others: Geographic Segmentation Analysis
Chapter 7: Radiotherapy Market by End User
7.1 Radiotherapy Market Snapshot and Growth Engine
7.2 Radiotherapy Market Overview
7.3 Hospitals
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Hospitals: Geographic Segmentation Analysis
7.4 Specialty Clinics
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Specialty Clinics: Geographic Segmentation Analysis
7.5 Ambulatory Surgical Centers (ASCs)
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Ambulatory Surgical Centers (ASCs): Geographic Segmentation Analysis
7.6 Others
7.6.1 Introduction and Market Overview
7.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.6.3 Key Market Trends, Growth Factors and Opportunities
7.6.4 Others: Geographic Segmentation Analysis
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Radiotherapy Market Share by Manufacturer (2023)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 VARIAN MEDICAL SYSTEMS (USA)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 SIEMENS HEALTHINEERS (GERMANY)
8.4 ELEKTA AB (SWEDEN)
8.5 ACCURAY INCORPORATED (USA)
8.6 CANON MEDICAL SYSTEMS CORPORATION (JAPAN)
8.7 GE HEALTHCARE (USA)
8.8 IBA (BELGIUM)
8.9 RAYSEARCH LABORATORIES AB (SWEDEN)
8.10 SUMITOMO HEAVY INDUSTRIES (JAPAN)
8.11 ISORAY INC. (USA)
8.12 VIEWRAY INC. (USA)
8.13 MITSUBISHI ELECTRIC CORPORATION (JAPAN)
8.14 OTHER ACTIVE PLAYERS
Chapter 9: Global Radiotherapy Market By Region
9.1 Overview
9.2. North America Radiotherapy Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size By Type
9.2.4.1 External Beam Radiotherapy
9.2.4.2 Internal Beam Radiotherapy (Brachytherapy)
9.2.4.3 Systemic Radiotherapy
9.2.5 Historic and Forecasted Market Size By Technology
9.2.5.1 Intensity-Modulated Radiation Therapy (IMRT)
9.2.5.2 Image-Guided Radiation Therapy (IGRT)
9.2.5.3 Stereotactic Technology
9.2.5.4 Proton Beam Therapy
9.2.5.5 3D Conformal Radiotherapy
9.2.5.6 Others
9.2.6 Historic and Forecasted Market Size By Application
9.2.6.1 Prostate Cancer
9.2.6.2 Breast Cancer
9.2.6.3 Lung Cancer
9.2.6.4 Colorectal Cancer
9.2.6.5 Head and Neck Cancer
9.2.6.6 Others
9.2.7 Historic and Forecasted Market Size By End User
9.2.7.1 Hospitals
9.2.7.2 Specialty Clinics
9.2.7.3 Ambulatory Surgical Centers (ASCs)
9.2.7.4 Others
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Radiotherapy Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size By Type
9.3.4.1 External Beam Radiotherapy
9.3.4.2 Internal Beam Radiotherapy (Brachytherapy)
9.3.4.3 Systemic Radiotherapy
9.3.5 Historic and Forecasted Market Size By Technology
9.3.5.1 Intensity-Modulated Radiation Therapy (IMRT)
9.3.5.2 Image-Guided Radiation Therapy (IGRT)
9.3.5.3 Stereotactic Technology
9.3.5.4 Proton Beam Therapy
9.3.5.5 3D Conformal Radiotherapy
9.3.5.6 Others
9.3.6 Historic and Forecasted Market Size By Application
9.3.6.1 Prostate Cancer
9.3.6.2 Breast Cancer
9.3.6.3 Lung Cancer
9.3.6.4 Colorectal Cancer
9.3.6.5 Head and Neck Cancer
9.3.6.6 Others
9.3.7 Historic and Forecasted Market Size By End User
9.3.7.1 Hospitals
9.3.7.2 Specialty Clinics
9.3.7.3 Ambulatory Surgical Centers (ASCs)
9.3.7.4 Others
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Radiotherapy Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size By Type
9.4.4.1 External Beam Radiotherapy
9.4.4.2 Internal Beam Radiotherapy (Brachytherapy)
9.4.4.3 Systemic Radiotherapy
9.4.5 Historic and Forecasted Market Size By Technology
9.4.5.1 Intensity-Modulated Radiation Therapy (IMRT)
9.4.5.2 Image-Guided Radiation Therapy (IGRT)
9.4.5.3 Stereotactic Technology
9.4.5.4 Proton Beam Therapy
9.4.5.5 3D Conformal Radiotherapy
9.4.5.6 Others
9.4.6 Historic and Forecasted Market Size By Application
9.4.6.1 Prostate Cancer
9.4.6.2 Breast Cancer
9.4.6.3 Lung Cancer
9.4.6.4 Colorectal Cancer
9.4.6.5 Head and Neck Cancer
9.4.6.6 Others
9.4.7 Historic and Forecasted Market Size By End User
9.4.7.1 Hospitals
9.4.7.2 Specialty Clinics
9.4.7.3 Ambulatory Surgical Centers (ASCs)
9.4.7.4 Others
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Radiotherapy Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size By Type
9.5.4.1 External Beam Radiotherapy
9.5.4.2 Internal Beam Radiotherapy (Brachytherapy)
9.5.4.3 Systemic Radiotherapy
9.5.5 Historic and Forecasted Market Size By Technology
9.5.5.1 Intensity-Modulated Radiation Therapy (IMRT)
9.5.5.2 Image-Guided Radiation Therapy (IGRT)
9.5.5.3 Stereotactic Technology
9.5.5.4 Proton Beam Therapy
9.5.5.5 3D Conformal Radiotherapy
9.5.5.6 Others
9.5.6 Historic and Forecasted Market Size By Application
9.5.6.1 Prostate Cancer
9.5.6.2 Breast Cancer
9.5.6.3 Lung Cancer
9.5.6.4 Colorectal Cancer
9.5.6.5 Head and Neck Cancer
9.5.6.6 Others
9.5.7 Historic and Forecasted Market Size By End User
9.5.7.1 Hospitals
9.5.7.2 Specialty Clinics
9.5.7.3 Ambulatory Surgical Centers (ASCs)
9.5.7.4 Others
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Radiotherapy Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size By Type
9.6.4.1 External Beam Radiotherapy
9.6.4.2 Internal Beam Radiotherapy (Brachytherapy)
9.6.4.3 Systemic Radiotherapy
9.6.5 Historic and Forecasted Market Size By Technology
9.6.5.1 Intensity-Modulated Radiation Therapy (IMRT)
9.6.5.2 Image-Guided Radiation Therapy (IGRT)
9.6.5.3 Stereotactic Technology
9.6.5.4 Proton Beam Therapy
9.6.5.5 3D Conformal Radiotherapy
9.6.5.6 Others
9.6.6 Historic and Forecasted Market Size By Application
9.6.6.1 Prostate Cancer
9.6.6.2 Breast Cancer
9.6.6.3 Lung Cancer
9.6.6.4 Colorectal Cancer
9.6.6.5 Head and Neck Cancer
9.6.6.6 Others
9.6.7 Historic and Forecasted Market Size By End User
9.6.7.1 Hospitals
9.6.7.2 Specialty Clinics
9.6.7.3 Ambulatory Surgical Centers (ASCs)
9.6.7.4 Others
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Radiotherapy Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size By Type
9.7.4.1 External Beam Radiotherapy
9.7.4.2 Internal Beam Radiotherapy (Brachytherapy)
9.7.4.3 Systemic Radiotherapy
9.7.5 Historic and Forecasted Market Size By Technology
9.7.5.1 Intensity-Modulated Radiation Therapy (IMRT)
9.7.5.2 Image-Guided Radiation Therapy (IGRT)
9.7.5.3 Stereotactic Technology
9.7.5.4 Proton Beam Therapy
9.7.5.5 3D Conformal Radiotherapy
9.7.5.6 Others
9.7.6 Historic and Forecasted Market Size By Application
9.7.6.1 Prostate Cancer
9.7.6.2 Breast Cancer
9.7.6.3 Lung Cancer
9.7.6.4 Colorectal Cancer
9.7.6.5 Head and Neck Cancer
9.7.6.6 Others
9.7.7 Historic and Forecasted Market Size By End User
9.7.7.1 Hospitals
9.7.7.2 Specialty Clinics
9.7.7.3 Ambulatory Surgical Centers (ASCs)
9.7.7.4 Others
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Radiotherapy Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 11.19 Billion |
|
Forecast Period 2024-32 CAGR: |
4.26% |
Market Size in 2032: |
USD 16.29 Billion |
|
Segments Covered: |
By Type |
|
|
|
By Technology |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
